178 related articles for article (PubMed ID: 17537309)
41. [Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance].
Wei L; Song XR; Wang XW; Li M; Z uo WS
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):445-8. PubMed ID: 17152492
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy.
Hsu CH; Chen CL; Hong RL; Chen KL; Lin JF; Cheng AL
Oncology; 2002; 62(4):305-12. PubMed ID: 12138237
[TBL] [Abstract][Full Text] [Related]
43. [Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
Chen W; Zhou X; Xu Q; Guo W; Lin L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):404-7. PubMed ID: 12641948
[TBL] [Abstract][Full Text] [Related]
44. Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma.
Zhang ZP; Sun YL; Fu L; Gu F; Zhang L; Hao XS
Ai Zheng; 2009 Feb; 28(2):100-3. PubMed ID: 19550121
[TBL] [Abstract][Full Text] [Related]
45. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.
Kurbacher CM; Cree IA
Methods Mol Med; 2005; 110():101-20. PubMed ID: 15901931
[TBL] [Abstract][Full Text] [Related]
46. Effect and mechanism of peroxisome proliferator-activated receptor-γ on the drug resistance of the U-87 MG/CDDP human malignant glioma cell line.
Han S; Lv X; Wang Y; Gong H; Zhang C; Tong A; Zhang B; Yao H
Mol Med Rep; 2015 Aug; 12(2):2239-46. PubMed ID: 25891367
[TBL] [Abstract][Full Text] [Related]
47. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
[TBL] [Abstract][Full Text] [Related]
48. Thymidylate synthase activity, folates, and glutathione system in head and neck carcinoma and adjacent tissues.
Parise O; Janot F; Luboinski B; Massaad L; Albin N; Toussaint C; Verjus MA; Bonnay M; Gouyette A; Chabot GG
Head Neck; 1994; 16(2):158-64. PubMed ID: 8021136
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1.
Sun KX; Jiao JW; Chen S; Liu BL; Zhao Y
J Ovarian Res; 2015 Dec; 8():80. PubMed ID: 26626440
[TBL] [Abstract][Full Text] [Related]
50. Sensitivity to topoisomerase I inhibitors and cisplatin is associated with epidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines.
Ling YH; Donato NJ; Perez-Soler R
Cancer Chemother Pharmacol; 2001 Jun; 47(6):473-80. PubMed ID: 11459199
[TBL] [Abstract][Full Text] [Related]
51. [Expression and significance of P-glycoprotein, glutathione S-transferase-pi and Topoisomerase II in gastric carcinomas].
Qin F; Qin X; Zhang X; Jia HW
Ai Zheng; 2002 Feb; 21(2):167-70. PubMed ID: 12479068
[TBL] [Abstract][Full Text] [Related]
52. [Application of the improved MTT assay in predicting the intrinsic drug resistance of liver cancer].
Li QY; Wang Y; Yin ZF; Wu MC
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):333-5. PubMed ID: 17456363
[TBL] [Abstract][Full Text] [Related]
53. Heterogeneity of chemosensitivity of esophageal and gastric carcinoma.
Mercer SJ; Somers SS; Knight LA; Whitehouse PA; Sharma S; Di Nicolantonio F; Glaysher S; Toh S; Cree IA;
Anticancer Drugs; 2003 Jul; 14(6):397-403. PubMed ID: 12853879
[TBL] [Abstract][Full Text] [Related]
54. Heterogeneity of chemosensitivity in esophageal cancer using ATP-tumor chemosensitivity assay.
Ling ZQ; Qi CJ; Lu XX; Qian LJ; Gu LH; Zheng ZG; Zhao Q; Wang S; Fang XH; Yang ZX; Yin J; Mao WM
Acta Pharmacol Sin; 2012 Mar; 33(3):401-6. PubMed ID: 22286916
[TBL] [Abstract][Full Text] [Related]
55. [An immunohistological study on expression of glutathione S-transferase pi (form) in dysplastic and neoplastic human uterine cervix lesions].
Satoh T; Nishida M; Oki A; Ichikawa Y; Tsunoda H; Kubo T
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):522-8. PubMed ID: 8754394
[TBL] [Abstract][Full Text] [Related]
56. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
Wang W; Liu G; Zheng J
Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
[TBL] [Abstract][Full Text] [Related]
57. AQP5 silencing suppresses p38 MAPK signaling and improves drug resistance in colon cancer cells.
Shi X; Wu S; Yang Y; Tang L; Wang Y; Dong J; Lü B; Jiang G; Zhao W
Tumour Biol; 2014 Jul; 35(7):7035-45. PubMed ID: 24752576
[TBL] [Abstract][Full Text] [Related]
58. Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor Chemosensitivity Assay.
Boabang P; Kurbacher CM; Kohlhagen H; Waida A; Amo-Takyi BK
Anticancer Drugs; 2000 Nov; 11(10):843-8. PubMed ID: 11142692
[TBL] [Abstract][Full Text] [Related]
59. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
O'Meara AT; Sevin BU
Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy.
Kim KH; Kwon HC; Oh SY; Kim SH; Lee S; Kwon KA; Jang JS; Kim MC; Kim SJ; Kim HJ
Biomarkers; 2011 Feb; 16(1):74-82. PubMed ID: 21133646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
